Stabilization of internally administered pancreatic lipase
Patent 3991180 Issued on November 9, 1976. Estimated Expiration Date: 
November 9, 1993. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
November 9, 1993. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3081225 3256150 InventorsAssigneeApplicationNo. 512743 filed on 10/07/1974US Classes:424/94.6, Hydrolases (3. ) (e.g., urease, lipase, asparaginase, muramidase, etc.)424/477Containing proteins or derivatives thereofExaminersPrimary: Rosen, SamAttorney, Agent or FirmAbstractA method for treating exocrine pancreatic insufficiency is disclosed. The method comprises the administration of a stable solid medicinal preparation containing finely particulated lipase intimately admixed with Hammarsten's casein and a tabletting lubricant, whereby a hydraulic pressure of about 2000 to about 5000 psi is employed.Other References
| |
